Oral GLP‑1 Agent Elecoglipron Triggers Up to 12% Weight Loss in Adults
A clinical trial published on June 11, 2026 reports that elecoglipron, a once‑daily oral GLP‑1 receptor agonist, led adults with obesity or excess weight to lose as much as 11.8 % of their body…